Dr. Philip Mease, a renowned rheumatologist, presents compelling findings on the long-term safety of Bimekizumab for treating axial spondyloarthritis and psoriatic arthritis. Meanwhile, Dr. Eric Dein dives into the nuanced world of rheumatoid arthritis, discussing the critical distinctions between low disease activity and clinical remission. They also explore the implications of statin use alongside JAK inhibitors, shedding light on how these factors affect treatment strategies. Tune in for insights that could reshape RA management!

Dr. Philip J. Mease, an ACR Master and leading researcher on fibromyalgia in psoriatic arthritis, shares insights from his groundbreaking study on pain prevalence in psoriatic arthritis patients. He discusses the significant interplay between fibromyalgia and disease severity, revealing how chronic pain mechanisms complicate treatment. Dr. Mease emphasizes the importance of tailored strategies for pain management and reflects on the personal narratives that shape clinical research. A captivating look into the evolving landscape of rheumatology!

Dr. Philip J. Mease, a leading rheumatologist specializing in psoriatic arthritis, provides invaluable insights into diagnosing and treating PsA. He discusses the importance of differentiating joint pain causes and highlights the role of collaboration between dermatologists and rheumatologists. Dr. Mease also explores treatment advancements, including the significance of biomarkers and aggressive strategies to minimize long-term damage. Additionally, he dives into gender differences in treatment responses and the challenges of managing complex cases, advocating for a multidisciplinary approach.